We [40] and others [41,42,43,44,45] previously showed that brain-derived neuronal and glial markers, such as neurofilament light-chain (NF-L) and glial fibrillary acidic protein (GFAP), can be predictive biomarkers for stroke severity on admission and functional outcome. This evidence concerns the gene NEFL and stroke disorder.